Skip to main content
Carl Zeiss Meditec AG logo

Carl Zeiss Meditec AG — Investor Relations & Filings

Ticker · AFX ISIN · DE0005313704 LEI · 529900GRL4MZ8NMOOK95 F Manufacturing
Open in API
Filings indexed 529 across all filing types
Latest filing 2025-05-14 Interim / Quarterly Rep…
Country DE Germany
Listing F AFX

About Carl Zeiss Meditec AG

https://www.zeiss.com/meditec-ag/en/hom…

Carl Zeiss Meditec AG is a leading global medical technology company with two strategic business units: Ophthalmology and Microsurgery. The Ophthalmology unit offers a comprehensive portfolio for the diagnosis and treatment of eye diseases, including diagnostic systems, surgical lasers, and intraocular lenses. The Microsurgery unit provides innovative visualization solutions, such as surgical microscopes, for medical disciplines including neurosurgery, spinal surgery, ENT, and dentistry. The company's technologies and application-oriented solutions are designed to help doctors improve the quality of life of their patients and advance medical progress.

Recent filings

Filing Released Lang Actions
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.10.2024 bis zum 31.03.2025
Interim / Quarterly Report Classification · 1% confidence The document is a 'Halbjahresfinanzbericht' (Half-Year Financial Report) for Carl Zeiss Meditec AG for the period 01.10.2024 to 31.03.2025. It contains detailed financial statements, including income statements, cash flow data, and management discussion and analysis (Konzernlagebericht). Since it covers a period shorter than a full fiscal year and provides substantive financial data, it is classified as an Interim/Quarterly Report. H1 2025
2025-05-14 German
Carl Zeiss Meditec achieves revenue growth and stable operating profit in the first six months of 2024/25
Earnings Release Classification · 1% confidence The document explicitly states it covers results for the 'first six months of fiscal year 2024/25' and provides detailed revenue, EBITA, and margin figures for this period, comparing them to the prior year. The keywords 'Half Year Report/Half Year Results' are present. This content structure is characteristic of a comprehensive interim financial report, which aligns with the definition of an Interim / Quarterly Report (IR). Although it is presented as a news release, the core content is the half-year financial performance summary, not just a brief announcement of results (ER) or a link to a report (RPA/RNS). H1 2025
2025-05-13 English
Change of President and CEO at Carl Zeiss Meditec AG
Board/Management Information Classification · 1% confidence The document is a formal announcement dated May 7, 2025, detailing a significant change in senior leadership: the stepping down of the President and CEO (Dr. Markus Weber) and the appointment of his successor (Maximilian Foerst) effective June 1, 2025. This content directly matches the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-05-08 English
Change of President and CEO at Carl Zeiss Meditec AG
Board/Management Information Classification · 1% confidence The document is an 'Ad-hoc' announcement dated May 7, 2025, explicitly titled 'Change of President and CEO at Carl Zeiss Meditec AG'. It details the agreement by the supervisory board regarding the handover of the CEO position from Dr. Markus Weber to Maximilian Foerst, effective May 31, 2025. This content directly relates to changes in senior management personnel. According to the definitions, this falls under 'Board/Management Information' (Code: MANG). The document is short and is an announcement, not a comprehensive report, confirming it is a specific event disclosure.
2025-05-07 English
Ergänzung der Veröffentlichung vom 25.02.2025
Notice of Dividend Amount Classification · 1% confidence The document text explicitly mentions 'Jahresabschluss zum Geschäftsjahr' (Annual Financial Statements for the fiscal year) covering 01.10.2023 to 30.09.2024, and details the 'Beschluss über die Gewinnverwendung' (Resolution on the appropriation of profits), including the dividend payment decided by the 'ordentliche Hauptversammlung' (Annual General Meeting). While it contains AGM elements (dividend resolution) and annual financial context, the core content is the formal resolution regarding the distribution of the annual profit/retained earnings, which is a key component often announced separately or as part of the AGM outcome. Since the document details the specific dividend amount and the carry-forward of retained earnings based on the AGM decision, it strongly relates to the dividend announcement (DIV) and the AGM outcome (AGM-R). Given the explicit calculation and announcement of the dividend amount ('Zahlung einer Dividende von EUR 0,60 je Stückaktie'), the most specific classification is Notice of Dividend Amount (DIV). It is not the full 10-K, nor is it just a general AGM presentation.
2025-04-30 German
Report Publication Announcement 2025
Report Publication Announcement Classification · 1% confidence The document is titled "Preliminary announcement of the publication of financial reports..." and explicitly states that the company "hereby announces that the following financial reports shall be disclosed," providing future disclosure dates (May 13, 2025) and links to the reports (half-year/Q2 financial report). The document itself is very short (2275 characters) and serves only to announce *when* and *where* the actual financial report will be available, rather than containing the full report content. This perfectly matches the definition of a Report Publication Announcement (RPA), which is used when a document announces the release of another report, adhering to the 'MENU VS MEAL' rule.
2025-04-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.